<ol id="ft7lx"></ol>

      <dfn id="ft7lx"></dfn>

        <ins id="ft7lx"></ins>
          <font id="ft7lx"></font>

          <var id="ft7lx"></var>

             
             
               
             
            Tetracaine·HCL
            Tetracaine
            Dyclonine Hydrochloride
             
            Bis(2-chloroethyl)am
            Ethyldiisopropylamin
            3-Chloropropylamine·
            Tripherylchlorometha
            Diethyl iminodiaceta
             
            1,1,1-tris(4-hydroxy
            N,N-Dimethylpropiona
            BPTMC;BISP-TMC; Bisp...
            4,4'-Dichlorobenzoph
             
               
               
             

            Yumen Qianhua Pharmaceutical Co., Ltd(ChangzhouTianhua Pharmaceutical CO., LTD.) was founded as Jintan Tianhua Chemical New Technology Institute in 1995, with the fixed assets of RMB 80 million and covering 40,000sqm. The company has more than 60 people including 20 technicians. It adjoins Shanghai and Nanjing enjoying transport facilitation.

            Tianhua is a high technical enterprise which is engaged in R& D production, and technical sevice of API and intermediates. We also have the sovereignty for exporting and importing. They are mainly exported to Europe USA and Asia. We established our own high effective research and development team. Meanwhile we cooperate with domestic first-class universities, research institutes in technical development. We have more than 70 Tank Reactors, one GMP API product line, and advanced analysis machines.

            Tianhua was awarded ISO 90001, ISO 14001 in 2005 and 2007. We also have Japanese Government's Foreign Manufacturer API Certification. We passed FDA’s field inspection in July, 2011, Tetracaine·HCL , Tetracaine, and Terbinafine·HCL was successfully registered in FDA having NDC number ,DMF and EDMF.

            Tianhua has became one of the important suppliers in foreign and domestic APIs and intermediates.The annula volume of export is up to $6000000 just including Diethyl iminodiacetate, Benzamidine hydrochloride, 3-Chloropropylamine·HCL,and 2-phenylpropionic acid.

            In 2021, Yumen QIANHUA Pharmaceutical Co., Ltd. was newly built in Yumen, Gansu Province. The company covers an area of 136 mu. It is designed to produce 1000 tons of API and intermediates per year. It has four synthesis workshops and two API fine drying car rooms. It is expected to install 200 2000-5000l reactors, more than 50 centrifuges and drying equipment. At present, the first phase of the project has been completed and is expected to be put into operation in the second half of 2022.

            Taking international standards as the principal ,Tianhua strengtherns quality control and assurance on each link in the development,production and sales. In nowadays,we can provide not only good products ,more importantly we provide good services, including technical service and create value for customers, Therefore, we won international enterprises’ appreciation and favor,including Daiichi Sankyo Company Limited. Tianhua was awarded Hi-Tech Enterprise in 11, 2011 keeping AAA grade credit enterprise for many years. 

            Honest work, efficient services, customer NO.1 are Tianhua’s development goal forever!

             
             
             
             
             
            午夜理论片yy6080影院_人妻体验按摩调情BD_女人被做到高潮视频_国产黄色网址在线观看